Cynthia Sirard
Vermogen: 31 075 $ op 31-05-2026
Vermogen: 31 075 $ op 31-05-2026
Cynthia Sirard is currently Chief Medical Officer at Compass Therapeutics, Inc. since 2026.
Formerly, Dr. Sirard was Chief Medical Officer at Cypherpunk Technologies, Inc. from 2020 to 2025 and Medical Director at PAREXEL International Corp.
from 2003 to 2005.
Education includes undergraduate studies at the University of Massachusetts and a doctorate from Chicago Medical School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 27.500 ( 0,03% ) | 31 075 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. | Hoofd Techniek/Wetenschap/O&O | 31-07-2025 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01-01-2005 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leap Therapeutics, Inc.
Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Compass Therapeutics, Inc.
Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau